Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
Launched by JOHNS HOPKINS UNIVERSITY · Nov 10, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities," aims to discover the best way to encourage more Latino adults to get vaccinated against COVID-19. Researchers want to find out if training friends and family members to use a technique called motivational interviewing—where they listen and guide conversations about the vaccine—helps increase vaccination rates better than just providing general information about the vaccine. They are also looking into what factors make it easier or harder for Latino communities to get vaccinated.
To participate in this study, you need to be at least 18 years old, identify as Hispanic or Latino, and live in Maryland. If you have already received at least one COVID-19 vaccine in the last year, you can help others who are more hesitant about getting vaccinated. If you haven’t received any vaccines in the past 12 months, you can join as someone who is more uncertain about vaccination. Participants will learn about the study and what to expect, and their experiences will help improve vaccination efforts in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Eligibility criteria for index participants (eligibility for index participants is intended to select participants who are less vaccine hesitant):
- • Age 18 years or older, and
- • Self-identifies as Hispanic/Latino, and
- • Living in Maryland, and
- • Has received at least one COVID-19 vaccine/booster in the last 12 months.
- Eligibility criteria for primary and secondary network members (peers):
- • Eligibility for peers is intended to select for participants who are more vaccine hesitant (e.g. unvaccinated, or have not received at least one COVID-19 vaccine/booster in the last 12 months)
- • 18 years old or older, and
- • Self-identifies as Hispanic/Latino, and
- • Living in Maryland, and
- • Provide a study coupon to verify that they were referred by an index or a primary network member, and
- • Has not received at least one COVID-19 vaccine/booster in the last 12 months.
- Exclusion Criteria:
- • Previously participated in the study
- • Lacks capacity to consent
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Kathleen R Page, MD
Principal Investigator
Johns Hopkins University
Cui Yang, PhD
Principal Investigator
Rutgers University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported